Cited by 13Treatment of Major DepressionPsychiatric care and mental health servicesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; its reference list is not available.

Ratings of Early Major Depressive Disorder Symptom Change During a Brief Psychiatric Hospitalization

Abstract

Ratings of change in MDD severity during a brief psychiatric hospitalization were examined across informant sources to determine the extent of change from admission to discharge and if specific symptoms are especially likely to change. Study participants were 137 inpatients with a primary diagnosis of MDD. Symptom data were collected at admission and discharge from attending psychiatrists, nurses, and patients. Global ratings of MDD severity and specific MDD symptoms significantly decreased during the course of hospitalization. This effect held across informant sources. All symptoms were equally likely to change. Females were rated as more depressed at admission and discharge by psychiatrists, but no gender differences were seen in self-report or nurse ratings. Shorter length of stay and involuntary admission status were associated with greater reduction in MDD severity. The temporal course and magnitude of the symptom reduction may result in part from unique aspects of an inpatient setting or from an underreporting of symptoms. The association between a shorter length of stay and greater symptom reduction may reflect a distinction between treatment responders and nonresponders.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11089-005-5579-x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some studies indicate that a shorter length of stay is as effective as a longer length of stay (e.g., 30 days) in reducing symptoms of dementia, major depression, and schizophrenia.

    “Although some studies indicate that shorter LOS is as effective as longer LOS (e.g., 30 days) in reducing symptoms of dementia (Kunik et al., 2001), major depression (Pettit et al., 2005), and schizophrenia (Johnstone and Zolese, 1999)”

Citations

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 34 · Cited by 13

Research works printed but not linked: 28

  1. World Health Organization: The World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland, World Health Organization, 2002.
  2. Leon AC: Measuring onset of antidepressant action in clinical trials: An overview of definitions and methodology. Journal of Clinical Psychiatry 62(suppl4):12?16, 2001.
  3. Stahl SM, Nierenberg AA, Gorman JM: Evidence of early onset of antidepressant effect in randomized controlled trials. Journal of Clinical Psychiatry 62(suppl 4):17?23, 2001.
  4. Berlin I, Lavergne F: Early predictors of two month response with mianserin and selective serotonin reuptake inhibitors and influence of definition of outcome on prediction. European Psychiatry 13:138?142, 1998. · DOI
  5. Stassen HH, Angst J, Delini-Stula A: Onset of improvement under fluoxetine and moclobemide. European Psychiatry 13:128?133, 1998. · DOI
  6. Trivedi MH, Baker SM: Clinical significance of monitoring early symptom change to predict outcome. Journal of Clinical Psychiatry 62(suppl 4):27?33, 2001.
  7. Ferguson JM, Mendels J, Schwartz GE: Effects of reboxetine on Hamilton Depression Rating Scale factors from randomized, placebo-controlled trials in major depression. International Clinical Psychopharmacology 17:45?51, 2002. · DOI
  8. Worthington J, Fava M, Davidson K, et al: Patterns of improvement in depressive symptoms with fluoxetine treatment. Psychopharmacology Bulletin 31:223?226, 1995.
  9. Jonghe FD, Dekker J: Early symptomatic changes in patients treated with antidepressants. European Journal of Psychiatry 13:99?76, 1999.
  10. Hoencamp E, Haffmans PMJ, Duivenvoorden H, et al: Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy. Journal of Affective Disorders 31:235?246, 1994. · DOI
  11. Coryell W, Ziegler VE, Biggs JT: Symptoms as predictors of response to amitriptyline and nortriptyline. Journal of Affective Disorders 2:27?35, 1980. · DOI
  12. Fava M, Amsterdam JD, Deltito JA, et al: A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Annals of Clinical Psychiatry 10(4):145?150, 1998. · DOI
  13. Keitner GI, Ryan CE, Miller IW, et al: 12-month outcome of patientswith major depression and comorbid psychiatric or medical illness (compound depression). American Journal of Psychiatry 148:345?350, 1991. · DOI
  14. Tedlow J, Fava M, Uebelacker L, et al: Outcome definitions and predictors in depression. Psychotherapy and Psychosomatics 67:266?270, 1998. · DOI
  15. Lieberman PB, Wiitala SA, Elliot B, et al: Decreasing length of stay: Are there effects on outcomes of psychiatric hospitalization? American Journal of Psychiatry 155:905?909, 1998. · DOI
  16. Hamilton M: A rating scale for depression. Journal of Neurology, Neurosurgergy, and Psychiatry 23:56?62, 1960. · DOI · Paper page
  17. Muller H, Moller HJ: A regression analytical approach to estimate the onset of activity of antidepressants. European Psychiatry 13:134?137, 1998. · DOI
  18. Piersma HL, Boes JL: Agreement between patient self-report and clinician rating: Concurrence between the BSI and the GAF among psychiatric inpatients. Journal of Clinical Psychology 51(2):153?157, 1995. · DOI
  19. Joiner TE, Rudd MD, Rajab MH: Agreement between self- and clinician-rated suicidal symptoms in a clinical sample of young adults: Explaining discrepancies. Journal of Consulting and Clinical Psychology 67(2):171?176, 1999. · DOI
  20. Woerner MG, Mannuzza S, Kane JM: Anchoring the BPRS: An aid to improved reliability. Psychopharmacology Bulletin 24:112?117, 1988.
  21. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychological Reports 10:185?196, 1962.
  22. Faustman WO, Overall JE: Brief Psychiatric Rating Scale, in The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, 2nd ed. Edited by Maruish ME. Mahwah, NJ, Lawrence Erlbaum, 1999.
  23. Lachar D, Bailey SE, Rhoades HM, et al: Use of BPRS-A percent change scores to identify significant clinical improvement: Accuracy of treatment responseclassification in acute psychiatric inpatients. Psychology Research 89:258?268, 1999.
  24. Murphy DL, Pickar D, Alterman I: A social network approach and the revolving door patient, in Quantitative Techniques for the Evaluation of the Behavior of Psychiatric Patients. Edited by Burdoch EI, Sudilovsky A, Gershon S. New York, Marcel Dekker, 1982.
  25. Beck AT, Steer RA, Brown GK: Manual for Beck Depression Inventory-II. San Antonio, TX, Psychological Corporation, 1996. · DOI · Paper page
  26. Gibbons RD, Clarke DC, VonAmmon CS, et al: Application of modern psychometric theory in psychiatric research. Journal of Psychiatric Research 19(1):43?55, 1985. · DOI
  27. Tyrer P: Personality disorders and social functioning, in MeasuringHuman Problems. Edited by Peck DF, Shapiro CM. New York, Wiley, 1990.
  28. Cohen J, Cohen P: Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ, Lawrence Earlbaum, 1983.

Metadata

Authors
Pettit, J. W., Averill, P. M., Wassef, A. A., Gruber, N. P., & Schneider, L.
Affiliations
University of Houston (US)
Corresponding author
Pettit, Jeremy W.
Venue
Psychiatric Quarterly
Published
2005-03
Volume
76
Issue
1
Pages
33-48
ISSN
  • 0033-2720 (ISSN-L)
  • 1573-6709
OpenAlex
W2076340640
Cited by
13
References
34
Citations by year
2024: 1 · 2022: 2 · 2020: 1 · 2017: 1 · 2014: 2 · 2013: 2 · 2012: 1
FWCI
0.43
Type
journal article
Language
en
Open access
closed
Locations
  • Psychiatric Quarterly (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
major depressive disorder, symptom change, informant ratings, gender differences, length of hospital stay, involuntary admission, symptom underreporting, treatment response, inpatient depression
MeSH terms
Adult, Major Depressive Disorder, Female, Hospitalization, Humans, Length of Stay, Male, Psychotherapy, Brief, Time Factors, Observer Variation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review